# Covid-19 Antibody Responses in Cystic Fibrosis

> **NCT05012306** · — · UNKNOWN · sponsor: **Universitätsklinikum Köln** · enrollment: 500 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05012306
- **Lead sponsor:** Universitätsklinikum Köln
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-28
- **Primary completion:** 2024-05
- **Final completion:** 2024-05
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05012306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05012306, "Covid-19 Antibody Responses in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05012306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*